Cargando…
Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea
Purpose: Inhaled Corticosteroids (ICSs) and oral Leukotriene Receptor Antagonists (LTRAs) are commonly prescribed asthma preventers, however, concerns have been raised as to whether montelukast (LTRA) is associated with an increase in occurrences of neuropsychiatric side effects in children. Our stu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163376/ https://www.ncbi.nlm.nih.gov/pubmed/35668949 http://dx.doi.org/10.3389/fphar.2022.834116 |
_version_ | 1784719906105720832 |
---|---|
author | Seo, Min Sook Hillen, Jodie Kang, Dong Yoon Pratt, Nicole Shin, Ju-Young |
author_facet | Seo, Min Sook Hillen, Jodie Kang, Dong Yoon Pratt, Nicole Shin, Ju-Young |
author_sort | Seo, Min Sook |
collection | PubMed |
description | Purpose: Inhaled Corticosteroids (ICSs) and oral Leukotriene Receptor Antagonists (LTRAs) are commonly prescribed asthma preventers, however, concerns have been raised as to whether montelukast (LTRA) is associated with an increase in occurrences of neuropsychiatric side effects in children. Our study was conducted to observe prescribing patterns of asthma preventers among paediatric patients specifically focusing on ICSs and LTRAs between Australia and South Korea to see intercountry differences in the use of these medicines. Materials and Methods: The Health Insurance Review and Assessment Paediatric Patients Sample dataset for South Korea and data provided by Services Australia were used in the study. Paediatric patients aged between 3 and 19 with more than one dispensing of an asthma preventer and at least one reliever between 1 Jan 2018 and 31 December 2018 were selected. Prevalence per 1,00,000 persons and standardised prevalence were estimated. Results: A total of 3,58,470 patients (2,04,270 from South Korea and 1,54,200 from Australia) were included in the study. A higher prevalence of ICS-based inhalers was seen in Australia with 80.1% compared to 13.5% in South Korea. In addition, Australia showed a stronger tendency of prescribing high dose ICS-based inhalers compared to South Korea with 22.9% vs. 4.9%. In contrast, use of LTRAs was more prevalent in South Korea with 57.6% while in Australia, montelukast was the only LTRA dispensed at a proportion of 18.9%. Moreover, 29.9% of xanthines which are orally available preventers, were prescribed more frequently in South Korea compared to Australia (0.1%). Conclusion: Australia showed a tendency of prescribing ICS-based preventers whereas South Korea exhibited a preference towards the oral LTRAs. Given the potential risk of neuropsychiatric side effects among paediatric patients with montelukast, reasons for the high use of montelukast in South Korea should be investigated further. |
format | Online Article Text |
id | pubmed-9163376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91633762022-06-05 Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea Seo, Min Sook Hillen, Jodie Kang, Dong Yoon Pratt, Nicole Shin, Ju-Young Front Pharmacol Pharmacology Purpose: Inhaled Corticosteroids (ICSs) and oral Leukotriene Receptor Antagonists (LTRAs) are commonly prescribed asthma preventers, however, concerns have been raised as to whether montelukast (LTRA) is associated with an increase in occurrences of neuropsychiatric side effects in children. Our study was conducted to observe prescribing patterns of asthma preventers among paediatric patients specifically focusing on ICSs and LTRAs between Australia and South Korea to see intercountry differences in the use of these medicines. Materials and Methods: The Health Insurance Review and Assessment Paediatric Patients Sample dataset for South Korea and data provided by Services Australia were used in the study. Paediatric patients aged between 3 and 19 with more than one dispensing of an asthma preventer and at least one reliever between 1 Jan 2018 and 31 December 2018 were selected. Prevalence per 1,00,000 persons and standardised prevalence were estimated. Results: A total of 3,58,470 patients (2,04,270 from South Korea and 1,54,200 from Australia) were included in the study. A higher prevalence of ICS-based inhalers was seen in Australia with 80.1% compared to 13.5% in South Korea. In addition, Australia showed a stronger tendency of prescribing high dose ICS-based inhalers compared to South Korea with 22.9% vs. 4.9%. In contrast, use of LTRAs was more prevalent in South Korea with 57.6% while in Australia, montelukast was the only LTRA dispensed at a proportion of 18.9%. Moreover, 29.9% of xanthines which are orally available preventers, were prescribed more frequently in South Korea compared to Australia (0.1%). Conclusion: Australia showed a tendency of prescribing ICS-based preventers whereas South Korea exhibited a preference towards the oral LTRAs. Given the potential risk of neuropsychiatric side effects among paediatric patients with montelukast, reasons for the high use of montelukast in South Korea should be investigated further. Frontiers Media S.A. 2022-05-20 /pmc/articles/PMC9163376/ /pubmed/35668949 http://dx.doi.org/10.3389/fphar.2022.834116 Text en Copyright © 2022 Seo, Hillen, Kang, Pratt and Shin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Seo, Min Sook Hillen, Jodie Kang, Dong Yoon Pratt, Nicole Shin, Ju-Young Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea |
title | Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea |
title_full | Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea |
title_fullStr | Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea |
title_full_unstemmed | Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea |
title_short | Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea |
title_sort | prescription patterns of asthma preventers among children and adolescents between australia and south korea |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163376/ https://www.ncbi.nlm.nih.gov/pubmed/35668949 http://dx.doi.org/10.3389/fphar.2022.834116 |
work_keys_str_mv | AT seominsook prescriptionpatternsofasthmapreventersamongchildrenandadolescentsbetweenaustraliaandsouthkorea AT hillenjodie prescriptionpatternsofasthmapreventersamongchildrenandadolescentsbetweenaustraliaandsouthkorea AT kangdongyoon prescriptionpatternsofasthmapreventersamongchildrenandadolescentsbetweenaustraliaandsouthkorea AT prattnicole prescriptionpatternsofasthmapreventersamongchildrenandadolescentsbetweenaustraliaandsouthkorea AT shinjuyoung prescriptionpatternsofasthmapreventersamongchildrenandadolescentsbetweenaustraliaandsouthkorea |